Exane Derivatives Sanofi Transaction History

Exane Derivatives

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 10, 2020	SELL	$42.91 - $52.5 $330,407 - $404,250	-7,700 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$38.02 - $51.66 $292,754 - $397,782	7,700 New	7,700 $336,000
Q4 2018 Jan 31, 2019	SELL	$41.48 - $45.59 $41,480 - $45,590	-1,000 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$40.0 - $44.84 $40,000 - $44,840	1,000 New	1,000 $0

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.